Dec 10, 2004
NCT00083551: UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma
This study has been designed to evaluate whether "anti-angiogenesis" therapy with thalidomide and whether additional chemotherapy after...
268
Dec 23, 2000
IFM trial: Conventional chemo or high-dose therapy and auto bone marrow transplantation - NEJM 1996
IFM - (Intergroupe Francophone du Myélome) Time Frame: October 1990 and May 1993 IFM trial: Conventional chemo or high-dose therapy and...
53